Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

818 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Recruiting

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

NCT06150664

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +37 more
Locations
  • D&H Cancer Research Center Margate, Florida, United States
  • Florida Cancer Specialists - Lake Nona Orlando, Florida, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • University Cancer & Blood Center Athens, Georgia, United States
View Trial Details
Recruiting

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

NCT06841354

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • USA Mitchell Cancer Institute ( Site 0090) Mobile, Alabama, United States
  • Ironwood Cancer & Research Centers ( Site 0036) Chandler, Arizona, United States
  • City of Hope ( Site 0097) Duarte, California, United States
  • City of Hope Lennar Foundation Cancer Center ( Site 0099) Irvine, California, United States
View all 267 locations
View Trial Details
Recruiting

Intratumoral N17350 in Advanced Solid Tumors

NCT07339176

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Triple-Negative, +33 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • UCLA - Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View Trial Details
Recruiting

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

NCT06966700

Conditions
Breast Diseases, Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms, +6 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0066) Gilbert, Arizona, United States
  • Mayo Clinic Cancer Center ( Site 0034) Phoenix, Arizona, United States
  • University of Arizona Cancer Center ( Site 0035) Tucson, Arizona, United States
  • Roy and Patricia Disney Family Cancer Center ( Site 0055) Burbank, California, United States
View all 317 locations
View Trial Details
Recruiting

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NCT06465069

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +72 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
View all 38 locations
View Trial Details
Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

NCT06393374

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Infirmary Cancer Care ( Site 0001) Mobile, Alabama, United States
  • Ironwood Cancer & Research Centers-Research ( Site 0054) Chandler, Arizona, United States
  • MemorialCare Orange Coast Medical Center ( Site 9501) Fountain Valley, California, United States
  • Scripps Cancer Center ( Site 0052) La Jolla, California, United States
View all 306 locations
View Trial Details
Recruiting

Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC

NCT06078384

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • CHU Amiens Picardie_Site Sud Amiens, France
  • Institut Sainte Catherine Avignon, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
  • Institut Bergonié Bordeaux, France
View all 44 locations
View Trial Details

Related conditions